Hearing device manufacturer Audientes sees a golden opportunity on the US hearing aid market, and with the release of Tuesday's FDA proposal for the guidelines of the upcoming over-the-counter sales channel, the company has taken its plans for hearing device "Ven" up a gear.
On Tuesday, the FDA revealed its proposed guidelines meant to improve the access to affordable hearing aids for Americans. Following the proposal, which did not contain any surprises, it is now the hearing aid industry's move, says an analyst at DNB Markets.
It took several attempts and presidential intervention, but the US authority has finally released guidelines to ensure better and cheaper access to hearing aids.
Sennheiser's consumer division will not be fully integrated into Hearing aid manufacturer Sonova's operations until next year.
A serious setback for Demant's surgical division Oticon Medical, as the company has had to recall numerous implant devices due to a performance issue, in addition to halting the sales of said device, says President and CEO at Demant Søren Nielsen, who has launched a thorough investigation to locate the root cause.
Prior to the company's capital markets day, the hearing aid group Demant unveils management's medium and long-term visions.
By signing an agreement with a third partner, hearing aid manufacturer Audientes has achieved its 2021 resolution and now looks ahead to fourth quarter revenue.
GN Hearing and Demant both gained ground on the lucrative hearing aid sales channel for American veterans in September.
The newly proposed regulatory framework in the US for the over-the-counter sales channel of hearing aids is of no concern to Danish hearing healthcare companies, who predict Americans will continue to prioritize professional guidance over cheaper devices.
Hearing health company Nuheara, which is based in Australia, has so far primarily dealt with the market for earbuds with hearing enhancing features. Now, they have commenced a clinical trial to gain a foothold in the established market for medically approved hearing aids. The company plans to apply for FDA approval in the first quarter of 2022.
The hunt for the next CFO at WS Audiology has begun, after Søren Westh Lonning announced on Wednesday that he is stepping down due to health issues. The CFO role is both very attractive and challenging, says headhunter Henrik Brabrand, who has one man in particular in mind as a replacement.
Oticon Medical, the surgical division of hearing aid group Demant, has located a performance issue in a number of non-implanted Neuro Zti chochlear implants, and the company sees no other option than to immediately withdraw the product from the market.
.jpg)
According to Janne Vincent Kjær, senior equity analyst at Jyske Bank, it is most likely that a new Apple product would be aimed at people suffering mild hearing loss – which is the same target group of GN's Jabra Enhance Plus.
According to sources familiar with Apple plans, the tech titan is looking into ways that its Airpods product can be used as a solution for hearing health, reports the Wall Street Journal.
Søren Westh Lonning will step down in November to focus on ongoing health issues. An interim replacement has been found in Michael Tyroller, who has previously stepped in for a period last year.
Hearing healthcare company Audientes exceeds its own expectations with its self-fitting hearing device after making preorders available last week. Another new partnership has contributed to the sales success.
The year of 2021 was meant to bring two new product launches from hearing aid manufacturer GN Hearing, but its research and development division hasn't delivered. Subsequently, the company has dismissed its head of R&D and downgraded its guidances markedly, says CEO at GN Hearing.
Janne Vincent Kjær, a senior equity analyst at Jyske Bank, questions the explanation for GN's revised financial guidance for its hearing division, pointing to what she thinks are more likely causes for the lowered expectations.
Günther Pausch has been appointed the new head of research and development at GN Hearing.
GN is adjusting its financial guidance for GN Hearing considerably.
As its competetitor WS Audiology before it, hearing aid group Demant now commits to the climate initiative Science Based Targets. Demant enters with the goal of reducing its emissions with 50 percent in 2030.
The capital fund EQT has no intentions of selling its shares in WS Audiology for the time being.
In an open letter to US President Joe Biden, four senators sound the alarm over the chaos reigning on the hearing device market. Due to a lack of clear regulation ahead of the over-the-counter sales channel, low-cost manufacturers have begun selling "amplifiers" masked as real hearing aids, potentially harming users.
GN is not considering selling or seperating from its hearing aid division, GN Hearing, to instead focus on the fast-growing headset manufacturer, GN Audio, a recommendation that Nordea made in an analysis for its clients on Wednesday.
Nordea analysts argue that the GN Group should consider selling or seperating from its hearing aid division GN Hearing, freeing up funds for GN Audio instead.
Senior Validation Analyst, Zealand Pharma 
KLIFO is looking for a talented and committed Pharmacovigilance Associate based in Denmark 
Data Analytics & Visualization Manager Senior Programmer at Genmab 
GxP QA Compliance Manager for Quality Assurance 
CMC Project Manager 
Director of Biostatistics CMC Product Support Manager 
Senior Director, Global Regulatory Lead 
Regulatory Science Specialist 
Principal Statistician / Statistical Project Director 
QA Specialist wanted Medical Director 
Cleaning chemist 
Global Product Manager Senior Manager/Associate Director Regulatory Affairs 
Senior Clinical Trial Manager Chemist for Late Stage Analytical Development (1-year temporary position) Senior Legal Advisor 
Software Developer, Cardiac Applications – Medical Devices, DK Training manager Clinical Business Process Manager Senior Manager Pharmaceutical Development and Manufacturing 
Clinical Documentation Specialist Jr. Software Developer, Cardiac Applications – Medical Devices, DK 
